Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine
Miltiades, P, Lamprianidou, E, Vassilakopoulos, T P, Papageorgiou, S G, Galanopoulos, A G, Vakalopoulou, S, Garypidou, V, Papaioannou, M, Hadjiharissi, E, Pappa, V, Papadaki, H A, Spanoudakis, E, Tsatalas, K, Kotsianidis, I
Published in Blood cancer journal (New York) (28.02.2014)
Published in Blood cancer journal (New York) (28.02.2014)
Get full text
Journal Article
Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3− T cells represents a potential antitumor mechanism of azacitidine
Lamprianidou, Eleftheria, Kordella, Chryssoula, Kazachenka, Anastasiya, Zoulia, Emmanouela, Bernard, Elsa, Filia, Anastasia, Laidou, Stamatia, Garantziotis, Panayiotis, Vassilakopoulos, Theodoros P., Papageorgiou, Sotirios G., Pappa, Vassiliki, Galanopoulos, Athanasios G., Viniou, Nora, Nakou, Evangelia, Kalafati, Lydia, Chatzidimitriou, Anastasia, Kassiotis, George, Papaemmanuil, Elli, Mitroulis, Ioannis, Kotsianidis, Ioannis
Published in Blood advances (12.01.2021)
Published in Blood advances (12.01.2021)
Get full text
Journal Article